Inhibrx Biosciences, Inc. • INBX

Capital at risk.

About Inhibrx Biosciences, Inc.
Ticker
info
INBX
Trading on
info
NASDAQ
ISIN
info
US45720N1037
Industry
info
Biotechnology
Sector
info
Healthcare
CEO
info
Mark Paul Lappe
Headquarters
info
11025 North Torrey Pines Road, La Jolla, CA, United States, 92037
Employees
info
156
Website
info
https://inhibrx.com
Inhibrx Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of biologic therapeutics for people with life-threatening conditions. Its therapeutic candidates include INBRX-109, a tetravalent therapeutic candidate targeting death-receptor 5 to treat unresectable or metastatic conventional chondrosarcoma; and INBRX-106, a hexavalent sdAb-based therapeutic candidate targeting OX4 for the treatment of metastatic solid tumor, non-small cell lung cancer, melanoma, head and neck squamous cell carcinoma, gastric or gastroesophageal junction adenocarcinoma, renal cell carcinoma, and urothelial cell carcinoma. Inhibrx Biosciences, Inc. was incorporated in 2024 and is based in La Jolla, California.
Metrics
BasicAdvanced
Market cap
info
$487M
P/E ratio
info
-
EPS
info
-$16.57
Dividend Yield
info
0.00%
Beta
info
-
Forward P/E ratio
info
0
EBIDTA
info
$-96.2M
Ex dividend date
info
-
Price & volume
Market cap
info
$487M
Average daily volume
info
0.7M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
$0.00
Dividend yield
info
0.00%
Forward dividend per share
info
$0.00
Forward dividend yield
info
0.00%
Payout ratio
info
0.00%
Valuation
P/E ratio
info
0
Forward P/E
info
0
PEG ratio
info
-
Trailing P/E
info
0
Price to sales
info
347.75
Price to book
info
7.41
Earnings
EPS
info
-$16.57
EPS estimate (current quarter)
info
-$2.60
EPS estimate (next quarter)
info
-$2.65
EBITDA
info
$-96.2M
Revenues (TTM)
info
$1.4M
Revenues per share (TTM)
info
$0.09
Technicals
Beta
info
-
52-week High
info
$86.64
52-week Low
info
$10.81
50-day moving average
info
$26.87
200-day moving average
info
$17.49
Short ratio
info
6.46
Short %
info
6.87%
Management effectiveness
ROE (TTM)
info
-113.71%
ROA (TTM)
info
-26.29%
Profit margin
info
0.00%
Gross profit margin
info
$-172M
Operating margin
info
-2,106.85%
Growth
Quarterly earnings growth (YoY)
info
0.00%
Quarterly revenue growth (YoY)
info
1,200.00%
Share stats
Outstanding Shares
info
14.5M
Float
info
7.8M
Insiders %
info
27.17%
Institutions %
info
65.51%
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
-$2.84
-$1.48
-91.89%
Q3 • 24Missed
-$3.09
-$1.44
-114.58%
Q4 • 24Missed
-$2.80
-$1.41
-98.58%
Q1 • 25Missed
-$1.85
-$1.55
-19.35%
Q2 • 25Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$0M
$-43.3M
-∞%
Q1 • 25
$1.3M
$-28.7M
-2,204.15%
Q2 • 25
∞%
-33.84%
NaN%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$243M
$148M
61.08%
Q1 • 25
$212M
$144M
67.68%
Q2 • 25
-12.58%
-3.13%
10.81%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$-35.9M
$-0M
$99.8M
$-35.9M
Q1 • 25
$-30M
$0M
$0M
$-30M
Q2 • 25
-16.55%
-100.00%
-100.00%
-16.60%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Inhibrx Biosciences, Inc. share?
Collapse

Inhibrx Biosciences, Inc. shares are currently traded for undefined per share.

How many shares does Inhibrx Biosciences, Inc. have?
Collapse

Inhibrx Biosciences, Inc. currently has 14.5M shares.

Does Inhibrx Biosciences, Inc. pay dividends?
Collapse

No, Inhibrx Biosciences, Inc. doesn't pay dividends.

What is Inhibrx Biosciences, Inc. 52 week high?
Collapse

Inhibrx Biosciences, Inc. 52 week high is $86.64.

What is Inhibrx Biosciences, Inc. 52 week low?
Collapse

Inhibrx Biosciences, Inc. 52 week low is $10.81.

What is the 200-day moving average of Inhibrx Biosciences, Inc.?
Collapse

Inhibrx Biosciences, Inc. 200-day moving average is $17.49.

Who is Inhibrx Biosciences, Inc. CEO?
Collapse

The CEO of Inhibrx Biosciences, Inc. is Mark Paul Lappe.

How many employees Inhibrx Biosciences, Inc. has?
Collapse

Inhibrx Biosciences, Inc. has 156 employees.

What is the market cap of Inhibrx Biosciences, Inc.?
Collapse

The market cap of Inhibrx Biosciences, Inc. is $487M.

What is the P/E of Inhibrx Biosciences, Inc.?
Collapse

The current P/E of Inhibrx Biosciences, Inc. is null.

What is the EPS of Inhibrx Biosciences, Inc.?
Collapse

The EPS of Inhibrx Biosciences, Inc. is -$16.57.

What is the PEG Ratio of Inhibrx Biosciences, Inc.?
Collapse

The PEG Ratio of Inhibrx Biosciences, Inc. is null.